Y染色体AZFc区缺失患者的治疗结局分析

doi:10.3969/j.issn.1671-167X.2016.04.008

摘要/Abstract

摘要：

目的：探讨Y染色体无精子症因素（azoospermia factor，AZF）c区缺失患者治疗方案的选择。方法：对既往183例在北京大学第三医院诊治的Y染色体AZFc区缺失患者的资料进行回顾性分析，整理诊疗过程及结局，找出AZFc区缺失患者精液情况的特点。结果： 183例AZFc区缺失的患者中105例（57.4%，105/183）能够自行射出精子，其中103例（98.1%，103/105）为重度或者严重少精子症，98例通过规律的药物治疗后有6例（6.1%，6/98）自然受孕，其余99例行胞浆内单精子显微注射（intracytoplasmic sperm injection，ICSI）患者中有68例（68.7%，68/99）成功受孕。183例AZFc区缺失患者中78例临床表现为无精子症，其中49例（62.8%，49/78）先行睾丸穿刺取精术（ testicular sperm aspiration，TESA），21例（26.9%，21/78）直接行显微取精术（micro-dissection testicular sperm extraction，micro-TESE）。行TESA的患者中，17例（34.7%，17/49）找到精子，32例（65.3%，32/49）未找到精子，包括12例（37.5%，12/32）放弃治疗及20例（62.5%，20/32）选择行micro-TESE患者。截至最后随访，41位选择micro-TESE的患者中已有19例（46.3%，19/41）完成手术，其中11例（57.9%，11/19）成功找到精子，包括TESA失败后行micro-TESE的患者（6例）中的4例（66.6%，4/6）。无精子症AZFc区缺失患者中已经有7例行ICSI，4例（57.1%，4/7）成功受孕。结论： AZFc区缺失的患者中有精子者大部分为重度或严重少精子症，长期的药物治疗效果不佳，应及时行ICSI治疗；无精子的患者通过TESA取到精子的概率稍低，TESA失败后行micro-TESE取精仍有一定的成功率，因此，在某些情况下直接选择micro-TESE可以减少患者的多次受创。

关键词: 不育, 男性, Y染色体, 序列缺失, 生殖技术, 辅助, 治疗结果

Abstract:

Objective：To discuss the treatment options for patients with azoospermia factor (AZF) c microdeletion on Y chromosome. Methods: One hundred and eighty three patients, who were diagnosed as AZFc microdeletion on Y chromosome in Peking University Third Hospital, were recruited in our stu-dy. In order to get better treatment option for this kind of patients, we retrospectively analyzed their clinic data including the treatment process and pregnancy outcome and found out the characteristics of their semen. Results: Among the 183 patients, sperms can be found in ejaculated semen in 105 patients (57.4%, 105/183). One hundred and three patients (98.1%, 103/105) were diagnosed as severe or extremely severe oligospermia. Regular medication was given to 98 patients, 6 patients (6.1%, 6/98) of which got natural pregnancy. The other 99 patients who have sperms in their semen received intracytoplasmic sperm injection (ICSI), 68 patients (68.7%, 68/99) of which got pregnancy. Seventy eight patients were diagnosed as azoospermia among all the 183 patients. Forty nine patients received testicular sperm aspiration (TESA), and 21 patients choose to receive micro-TESE directly. Among the 49 patients with TESA, sperms were retrieved in 17 patients (34.7%, 17/49), and sperms were not retrieved in 32 patients (65.3%, 32/49), of which 12 patients (37.5%, 12/32) gave up treatment and 20 patients (62.5%, 20/32) choose micro-TESE. Among the 41 patients who choose to receive micro-TESE, ope-ration has been done on 19 patients, of which 11 patients (57.9%, 11/19) got sperms. Among the 11 patients, TESA has been done on 6 patients before microTESE, of which 4 patients (66.6%, 4/6) got sperms. ICSI has already been done on 7 azoospermia AZFc microdeletion patients who underwent micro-TESE, of which 4 patients (57.1%, 4/7) get pregnancy. Conclusion: AZFc microdeletion patients who had sperms were always diagnosed as severe or extremely severe oligospermia. ICSI was their first choice instead of drug therapy. For AZFc microdeletion patients who were diagnosed as azoospermia, TESA was one of their choices, however, the success rate is not high. Micro-TESE is still possible to get sperms even after the failure of TESA. Therefore, we may choose micro-TESE instead of TESA in some azoospermia patients in order to reduce surgical trauma on patients.

Key words: Infertility, male, Y chromosomes, Sequence deletion, Reproductive techniques, assisted, Treatment outcome

中图分类号:

R698.2

赵连明，姜辉，洪锴，林浩成，唐文豪，刘德风，毛加明，廉颖，马潞林. Y染色体AZFc区缺失患者的治疗结局分析[J]. 北京大学学报(医学版), 2016, 48(4): 607-611.

ZHAO Lian-ming, JIANG Hui, HONG Kai, LIN Hao-cheng, TANG Wen-hao, LIU De-feng, MAO Jia-ming, LIAN Yin, MA Lu-lin. Outcome of treatment of Y chromosome AZFc microdeletion patients[J]. Journal of Peking University(Health Sciences), 2016, 48(4): 607-611.

参考文献

相关文章 15

[1]	李怡,王丽瑜,刘晓强,周倜,吕季喆,谭建国. 不同材料及厚度椅旁CAD/CAM瓷贴面的边缘特征[J]. 北京大学学报（医学版）, 2022, 54(1): 140-145.
[2]	邱淑婷,朱玉佳,王时敏,王飞龙,叶红强,赵一姣,刘云松,王勇,周永胜. 姿势微笑位口唇对称参考平面的数字化构建及初步应用验证[J]. 北京大学学报（医学版）, 2022, 54(1): 193-199.
[3]	李伟浩,李伟,张学民,李清乐,焦洋,张韬,蒋京军,张小明. 去分支杂交手术和传统手术治疗胸腹主动脉瘤的结果比较[J]. 北京大学学报（医学版）, 2022, 54(1): 177-181.
[4]	朱正达,高岩,何汶秀,方鑫,刘洋,魏攀,闫志敏,华红. 红色诺卡氏菌细胞壁骨架治疗糜烂型口腔扁平苔藓的疗效及安全性[J]. 北京大学学报（医学版）, 2021, 53(5): 964-969.
[5]	刘承,马潞林. 前入路机器人辅助前列腺根治性切除术中改善排尿控制的经验[J]. 北京大学学报（医学版）, 2021, 53(4): 635-639.
[6]	杜强,洪锴,潘伯臣. 两种检测男性生殖道沙眼衣原体和解脲支原体方法的对比[J]. 北京大学学报（医学版）, 2021, 53(4): 785-788.
[7]	王鑫光,耿霄,李杨,吴天晨,李子剑,田华. 便携式导航与计算机导航辅助在全膝关节置换力线对准和手术时间的比较[J]. 北京大学学报（医学版）, 2021, 53(4): 728-733.
[8]	冯科,倪菁菁,夏彦清,曲晓伟,张慧娟,万锋,洪锴,张翠莲,郭海彬. 3例SUN5基因变异导致无头精子症的遗传学分析和助孕治疗结局[J]. 北京大学学报（医学版）, 2021, 53(4): 803-807.
[9]	李远骋, 崔闻心, 郭雪儿, 朱璠, 刘思辰, 贾碧波, 汪培, 马迎华. 青年学生男男性行为人群中人类免疫缺陷病毒阳性与阴性者获得性免疫缺陷综合征(艾滋病)相关知识与行为比较[J]. 北京大学学报（医学版）, 2021, 53(3): 511-517.
[10]	李新飞, 彭意吉, 余霄腾, 熊盛炜, 程嗣达, 丁光璞, 杨昆霖, 唐琦, 米悦, 吴静云, 张鹏, 谢家馨, 郝瀚, 王鹤, 邱建星, 杨建, 李学松, 周利群. 肾部分切除术前CT三维可视化评估标准的初步探究[J]. 北京大学学报（医学版）, 2021, 53(3): 613-622.
[11]	赵凯,常志芳,王志华,庞春艳,王永福. 基因沉默肽基精氨酸脱亚胺酶4的表达对胶原诱导关节炎小鼠肺间质病变的影响[J]. 北京大学学报（医学版）, 2021, 53(2): 235-239.
[12]	黄新瑞,李莎,高嵩. 冷冻电镜成像中噪声的滤波方法进展[J]. 北京大学学报（医学版）, 2021, 53(2): 425-433.
[13]	岳兆国,张海东,杨静文,侯建霞. 数字化评估CAD/CAM个性化基台与成品基台影响粘接剂残留的体外研究[J]. 北京大学学报（医学版）, 2021, 53(1): 69-75.
[14]	徐啸翔,曹烨,赵一姣,贾璐,谢秋菲. 数字化个齿托盘制取下颌全牙列全冠预备体印模的体外评价[J]. 北京大学学报（医学版）, 2021, 53(1): 54-61.
[15]	李峥,柳玉树,王时敏,张瑞,贾璐,叶红强,胡文杰,赵文艳,刘云松,周永胜. 数字化方法复制暂时修复体牙合面形态在重度磨耗病例中的应用[J]. 北京大学学报（医学版）, 2021, 53(1): 62-68.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed